Breaks Categories: News

FridayApr 06, 2018 12:57 pm

CannabisNewsBreaks – Xanthic Biopharma Inc. Receives Conditional Listing Approval from the CSE

Xanthic Biopharma, a premium cannabinoid life sciences and technology company, recently announced that it has been granted conditional listing approval from the Canadian Securities Exchange (“CSE”) to list its common shares under the ticker symbol xTHC. The listing is subject to the successful completion of customary listing requirements of the CSE. The company has requested April 19th as its first trading date. “We are thrilled to begin trading on the CSE especially on the eve of ‘4/20’. We are excited to have obtained the ticker symbol xTHC, which we feel is memorable and readily connected with “Xanthic”. Our team would…

Continue Reading

WednesdayApr 04, 2018 9:26 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Posts Product Development Update

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning issued a corporate update regarding the progress of its bio-cannabis product pipeline. Per the update, a 1% CBD Oral Micelle Solution developed in Germany is set to market and the company has completed development of two topical creams that employ its patented formulation and delivery systems. Pivot anticipates that it will have numerous products available for sale in Canada on the date legalization officially begins. The company also expects to begin sales in California as of the third quarter 2018, including the launch of its proprietary…

Continue Reading

TuesdayApr 03, 2018 3:09 pm

CannabisNewsBreaks – Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF) and CanniMed Therapeutics Inc. (TSX: CMED) Name Interim CEO of CanniMed

Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF), together with CanniMed Therapeutics Inc. (TSX: CMED), recently announced that Brent Zettl has resigned from his position as CEO of CanniMed. Andrċ Jérôme was appointed as interim CEO and Zettl will remain available to CanniMed and Aurora in an advisory capacity to assist during the integration period. This update comes as Aurora nears the completion of the acquisition of all the outstanding shares of CanniMed. "The integration of Aurora and CanniMed is well underway, and we anticipate updating the market frequently on developments as CanniMed is aligned with the Aurora Standard and expands…

Continue Reading

ThursdayMar 29, 2018 10:05 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Arrival of First Cannabis Shipment at University of Queensland

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the arrival of the first shipment of dried cannabis flower and oils from Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) at the University of Queensland’s Pharmacy Australia Centre of Excellence. Per the news release, testing of the imported cannabis strains in the application of PreveCeutical’s Sol-gel drug delivery technology is now expected to commence. The impending Sol-gel program aims to develop a system that will increase the bioavailability of drugs through the use of an innovative nose-to-brain delivery platform. The company notes that Sol-gels could…

Continue Reading

WednesdayMar 28, 2018 9:41 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Enters LOI to Acquire Flower Power Cannabis Pharms Inc.

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its entry into a letter of intent to acquire Flower Power Cannabis Pharms Inc., a retail brand experience cannabis company, as well as its wholly-owned subsidiary, High Way 10 Cannabis Pharms Inc. Per the update, High Way 10, located in southern Saskatchewan, is currently in the active review stage of Health Canada’s application process under the ACMPR, and its initial 16,000 sq. ft. facility is capable of producing roughly 1,500 kg of dried cannabis per annum. “We are very pleased Choom™ has increased its total…

Continue Reading

MondayMar 26, 2018 3:24 pm

CannabisNewsBreaks – Namaste Technologies, Inc. (CSE: N) (FRA: M5BQ) (OTC: NXTTF) Subsidiary Inks Medical Cannabis Supply Agreement with Clever Leaves

Namaste Technologies (CSE: N) (FRA: M5BQ) (OTC: NXTTF), through its wholly-owned subsidiary Cannmart Inc., has signed a medical cannabis product acquisition agreement with medical cannabis producer Clever Leaves with the assistance of Clever Leaves’ financial sponsor, Northern Swan Holdings, Inc. Clever Leaves is a vertically integrated, licensed producer of medical cannabis in Colombia that recently commenced construction of a 15+ hectare good agricultural collection practices compliant cultivation facility and Good Manufacturing Practices (“GMP”) Level-2 Extraction facility. Per the terms of the agreement, Cannmart will submit purchase orders to Clever Leaves for medical cannabis. Subject to approval by Health Canada, Cannmart…

Continue Reading

MondayMar 26, 2018 9:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Completes Integration of California Subsidiary

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has successfully completed the integration of its California subsidiary, ERS Holdings Ltd., under the guidance of Patrick Rolfes, president of Pivot Pharmaceuticals USA. Per the update, Pivot is currently preparing for a 2018 product launch in California, with a consumer-facing brand scheduled to be unveiled in the coming weeks. “As the Company prepares for legalization of cannabis in Canada, we continue to expand our business operations in the US market on a state-by-state basis, where regulations permit,” Dr. Patrick Frankham, Pivot CEO, stated…

Continue Reading

FridayMar 23, 2018 3:47 pm

CannabisNewsBreaks – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) Inks Partnership Agreement with Kawacatoose First Nation

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, recently announced that it has signed a partnership agreement with Kawacatoose First Nation (“KFN”). The two companies will collaborate to cultivate and manufacture high yielding CBD derived from industrial hemp. The companies also intend to explore additional economic opportunities in commercializing the hemp by-product into everyday finished goods. Per the terms of the agreement, KFN will provide up to 3,000 farmable acres of land, based on availability and subject to certain conditions being met by both parties on…

Continue Reading

ThursdayMar 22, 2018 10:41 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Notice of Allowance from United States Patent and Trademark Office

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has received a new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") covering "composition of matter" claims which protect the specific combination of substances that enables improved taste and the bioabsorption properties of its DehydraTECH™ technology for the delivery of cannabinoids. The newly-granted patent is a substantial addition to Lexaria's previously granted manufacturing method of use patent. In accordance with USPTO practice, there is no opposition period between allowance and issuance. The patent application number is 15/225,802 titled, "Food and…

Continue Reading

TuesdayMar 20, 2018 11:31 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Filing of New Patent Application

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has filed a new patent application with the United States Patent and Trademark Office for the use of its DehydraTECH™ technology to improve the speed and quantity of absorption of active pharmaceutical ingredients through the skin. This update comes on the heels of Lexaria’s recently detailed successful laboratory evaluation of DehydraTECH™ in the transdermal delivery of cannabidiol. Per company data, the platform demonstrated as much as a 225 percent increase in CBD permeability when compared to control formulations featuring leading commercial penetration enhancers, as…

Continue Reading